Skip to main content

Advertisement

Table 3 Fatty acid composition (%) of plasma for the omega-3 supplementation (N-3 PUFA) and placebo groups

From: 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo

  N-3 PUFA Placebo  
Fatty acids Pre Post Pre Post p
EPA (20:5 n-3) 0.41 ± 0.16 0.68 ± 0.27* 0.59 ± 0.34 0.49 ± 0.24 0.004
DPA (22:5 n-3) 0.29 ± 0.092 0.35 ± 0.091 0.31 ± 0.095 0.30 ± 0.055 0.087
DHA (22:6 n-3) 1.61 ± 0.32 1.81 ± 0.43 1.65 ± 0.45 1.56 ± 0.042 0.058
α-Linolenic (18:3 n-3) 0.39 ± 0.12 0.38 ± 0.18 0.41 ± 0.10 0.36 ± 0.11 0.53
Linoleic (18:2 n-6) 21.68 ± 2.85 21.01 ± 1.89 22.75 ± 3.67 21.93 ± 3.16 0.86
Arachidonic (20:4 n-6) 8.00 ± 2.07 7.43 ± 1.69 7.42 ± 1.93 7.03 ± 1.97 0.86
  1. *Significant group by time interaction. All values are mean ± SD percentages for the omega-3 supplementation group (N-3 PUFA) and placebo group (PLA). Pre, data collected prior to 21-days of supplementation. Post, data collect after 21-day of supplementation. Data are shown as mean ± SD